Gabelli Funds’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Gabelli Funds’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-425,208	Closed	-$23.4M	–	1460
2022 Q2	$23.4M	Buy	+425,208	New	+$22.3M	0.18%	153

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Gabelli Funds's SRRA Position: Q3 2022 in Review

Gabelli Funds sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 425,208 shares — an estimated $23.4M sold.

Gabelli Funds first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $23.4M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Gabelli Funds reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Gabelli Funds sold 425,208 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $23.4M.
Gabelli Funds first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Gabelli Funds's Sierra Oncology, Inc. Common Stock position peaked at $23.4M in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Gabelli Funds's 13F filing for Q3 2022, filed 10 Nov 2022.